Supplemental Figures and Figure Legends

Total Page:16

File Type:pdf, Size:1020Kb

Supplemental Figures and Figure Legends Supplemental Figures and Figure Legends A Source Hirst REMC 1 Source Hirst REMC Source Hirst Source 1 0.9 0.8 0.7 0.6 0.9 REMC 1 0.9 0.8 0.7 0.6 Source Source B Penis_Foreskin_Melanocyte_Primary_Cells_skin03 Penis_Foreskin_Melanocyte_Primary_Cells_skin01 Penis_Foreskin_Melanocyte_Primary_Cells_skin03 0.8HUVEC Penis_Foreskin_Melanocyte_Primary_Cells_skin01 Penis_Foreskin_Fibroblast_Primary_Cells_skin02 Penis_Foreskin_Fibroblast_Primary_Cells_skin01 HUVEC H1_Derived_Mesenchymal_Stem_Cells Penis_Foreskin_Fibroblast_Primary_Cells_skin02 NHLF 0.7HSMM Penis_Foreskin_Fibroblast_Primary_Cells_skin01 Universal_Human_Reference H1_Derived_Mesenchymal_Stem_Cells NHEK Breast_vHMEC NHLF HMEC HSMM Penis_Foreskin_Keratinocyte_Primary_Cells_skin03 0.6Penis_Foreskin_Keratinocyte_Primary_Cells_skin02 Universal_Human_Reference Breast_Myoepithelial_Cells NHEK HELA A549 Breast_vHMEC HEPG2 HMEC hESC_Derived_CD56+_Mesoderm_Cultured_Cells H1_BMP4_Derived_Trophoblast_Cultured_Cells Penis_Foreskin_Keratinocyte_Primary_Cells_skin03 HUES64_Cell_Line Penis_Foreskin_Keratinocyte_Primary_Cells_skin02 H1_BMP4_Derived_Mesendoderm_Cultured_Cells Breast_Myoepithelial_Cells 4star H1_Cell_Line HELA hESC_Derived_CD56+_Ectoderm_Cultured_Cells A549 H1_Derived_Neuronal_Progenitor_Cultured_Cells hESC_Derived_CD184+_Endoderm_Cultured_Cells HEPG2 Neurosphere_Cultured_Cells_Ganglionic_Eminence_Derived hESC_Derived_CD56+_Mesoderm_Cultured_Cells Neurosphere_Cultured_Cells_Cortex_Derived Brain_Germinal_Matrix H1_BMP4_Derived_Trophoblast_Cultured_Cells Fetal_Brain_Female HUES64_Cell_Line Brain_Hippocampus_Middle Pancreas H1_BMP4_Derived_Mesendoderm_Cultured_Cells Pancreatic_Islets 4star Fetal_Intestine_Small Fetal_Intestine_Large H1_Cell_Line Lung hESC_Derived_CD56+_Ectoderm_Cultured_Cells Gastric Esophagus H1_Derived_Neuronal_Progenitor_Cultured_Cells Small_Intestine hESC_Derived_CD184+_Endoderm_Cultured_Cells Sigmoid_Colon Aorta Neurosphere_Cultured_Cells_Ganglionic_Eminence_Derived Right_Ventricle Neurosphere_Cultured_Cells_Cortex_Derived Left_Ventricle Brain_Germinal_Matrix Right_Atrium Psoas_Muscle Fetal_Brain_Female Ovary Brain_Hippocampus_Middle Spleen Thymus Pancreas Adult_Liver Pancreatic_Islets K562 GM12878 Cluster Blood Fetal_Intestine_Small Erythroid Fetal_Intestine_Large BCell Monocyte Lung CD8_Naive_Primary_Cells Gastric CD4_Naive_Primary_Cells CD4_Memory_Primary_Cells Esophagus TCell2 Small_Intestine TCell1 Peripheral_Blood_Mononuclear_Primary_Cells Sigmoid_Colon Mobilized_CD34_Primary_Cells_Female Aorta MEP GMP Right_Ventricle CMP Left_Ventricle CD34.CD38. Right_Atrium Psoas_Muscle Ovary Spleen Thymus Adult_Liver K562 GM12878 Erythroid BCell 1 Monocyte CD8_Naive_Primary_Cells CD4_Naive_Primary_Cells CD4_Memory_Primary_Cells TCell2 TCell1 Peripheral_Blood_Mononuclear_Primary_Cells Mobilized_CD34_Primary_Cells_Female MEP GMP CMP CD34.CD38. CD34.CD38. CMP GMP MEP Mobilized_CD34_Primary_Cells_Female Peripheral_Blood_Mononuclear_Primary_Cells TCell1 TCell2 CD4_Memory_Primary_Cells CD4_Naive_Primary_Cells CD8_Naive_Primary_Cells Monocyte BCell Erythroid GM12878 K562 Adult_Liver Thymus Spleen Ovary Psoas_Muscle Right_Atrium Left_Ventricle Right_Ventricle Aorta Sigmoid_Colon Small_Intestine Esophagus Gastric Lung Fetal_Intestine_Large Fetal_Intestine_Small Pancreatic_Islets Pancreas Brain_Hippocampus_Middle Fetal_Brain_Female Brain_Germinal_Matrix Neurosphere_Cultured_Cells_Cortex_Derived Neurosphere_Cultured_Cells_Ganglionic_Eminence_Derived hESC_Derived_CD184+_Endoderm_Cultured_Cells H1_Derived_Neuronal_Progenitor_Cultured_Cells hESC_Derived_CD56+_Ectoderm_Cultured_Cells H1_Cell_Line 4star H1_BMP4_Derived_Mesendoderm_Cultured_Cells HUES64_Cell_Line H1_BMP4_Derived_Trophoblast_Cultured_Cells hESC_Derived_CD56+_Mesoderm_Cultured_Cells HEPG2 A549 HELA Breast_Myoepithelial_Cells Penis_Foreskin_Keratinocyte_Primary_Cells_skin02 Penis_Foreskin_Keratinocyte_Primary_Cells_skin03 HMEC Breast_vHMEC NHEK Universal_Human_Reference HSMM NHLF H1_Derived_Mesenchymal_Stem_Cells Penis_Foreskin_Fibroblast_Primary_Cells_skin01 Penis_Foreskin_Fibroblast_Primary_Cells_skin02 HUVEC Penis_Foreskin_Melanocyte_Primary_Cells_skin01 Penis_Foreskin_Melanocyte_Primary_Cells_skin03 Figure S1. Related to Figure 1. Sorting strategy for hematopoietic populations profiled in this study. A) Representative examples of sorting strategies for CD34+CD38-, CMP, GMP, MEP, monocyte, erythroid precursors and B cell isolated from pool of cord blood. B) Unsupervised hierarchical clustering and heatmap of pairwise spearman correlations for protein coding gene RPKM values across blood cell types profiled in this study in the context of all cell types profiled by NIH Epigenome RoadMap Consortium. The cluster of blood cell types is indicated by the shaded box. 2 A CD14 CD19 CD34 C 250 150 200 60 150 100 40 100 20 50 50 D 0 0 0 CD38 CD7 FLT3 CD34.CD38. 60 CMP GMP 60 40 100 MEP 40 Monocyte Erythroid 1.00 RPKM RPKM 20 50 E 20 BCell TCell1 0 0 0 3 GYPA ITGAM PTPRC black 1.00 2000 80 300 1500 60 1000 40 200 F 500 20 100 0 2 0 0 B G H Log10(q-value) 0.75 TAL1 3 3 Mark 22 H3K27me3 1 Mark H3K36me3 H3K27me3 1 1 H3K36me3 H3K4me3 log10(RPKM) H3K4me3 0.75 log10(RPKM) 00 Log10(RPKM) Cell -1-1 - CMP MEP GMP B-Cell T-Cell H1 Monocyte Erythroid 0 CD34+CD38- CMP GMP MEP T Cell MPO B Cell CD34+CD38− MonocyteErythroid CD34+CD38 CMP Cell GMP 0.50 Cella$n Cell H1 MEP CB CD34+ CD38- MPL 1 CD34+CD38− -1CMP Monocyte TFRC 0.5 GMP CMP Erythroid VWF MEP GMP B−Cell 0 0.50 TAL1 Group CMP GMP MEP T-Cell a$n B-CellMEP T−Cell Erythroid/Megakaryocyte EPOR -0.5 Monocyte Erythroid Monocyte/Granulocyte Monocyte GATA1 -1 CD34+CD38-CD34+CD38- Compartment Erythroid GATA3 B−Cell HOXB5 T−Cell ID2 NR4A20.25 IL3RA 3 ELANE CSF2RA CEBPA 0.25 MPO CD33 SPI1 Group 0.00 H1 CD34+CD38− CMP GMP MEP Monocyte Erythroid B−Cell T−Cell a$Cell 0.00 H1 CD34+CD38− CMP GMP MEP Monocyte Erythroid B−Cell T−Cell a$Cell Figure S2. Related to Figure 1. Each progenitor populations possesses a unique expression profile. A) Expression (RPKM) of cell type specific cell surface marker genes across cell types as indicated by the colour legend on the bottom right. B) Expression of previously identified progenitor population specific genes across CD34+CD38-, CMP, GMP and MEP. Gene ontology analysis of GMP (C), MEP (D), CD34+CD38- (E), and CMP (F) up-regulated genes identified by DEFine (FDR > 0.01). G) Genome browser view of H3K4me3 density in progenitor populations at the TAL1 and MPO locus across CD34+CD38-, CMP, GMP and MEP. H) Expression of genes marked with H3K4me3, H3K27me3 or H3K36me3 across each cell type. 4 a$Cell Cell − T Cell − B Erythroid Monocyte MEP GMP CMP − CD34+CD38 H1 ✱✱✱ 0.00 DMSO Control ✱✱✱ DMSO Control ✱✱✱ DMSO Control A GMP vs Erythroid GMP vs MEP GMP vs MEP✱✱✱ MEP vs Monocyte ATRA ✱✱✱✱✱✱ DMSOATRA Control ✱✱✱ ATRA 4 ✱✱✱ ✱✱✱ GMP up-regulated GMP up-regulated MEP up-regulated MEP 4up-regulated ✱✱✱ GSK-J4 4 ✱✱✱✱✱✱ ✱✱✱ ATRA GSK-J4 ✱✱✱ ✱✱✱ GSK-J4 ✱✱✱ ✱✱✱ DMSO Control✱✱✱ DMSO Control ✱✱✱ ✱✱✱ 300 4 ✱✱✱ ✱✱✱ ns ✱✱✱ EPZ ✱✱✱ns ✱✱✱ ✱✱✱ ATRA GSK-J4EPZ ATRA ns ✱✱✱ EPZ 4 ✱✱✱ ✱✱✱ DMSO Control ✱✱✱ 4 ✱✱✱ ✱✱✱ ✱✱✱ GSK-J4✱✱✱✱✱✱ GSK-J4 ✱✱✱ CMP ATRA + GSK-J4 ✱✱✱ ✱✱✱ ✱✱✱ DMSO Control ✱✱✱ DMSO Control ns ✱✱✱ ✱✱✱ ✱✱✱EPZ✱✱✱✱✱✱ DMSO ControlATRA✱✱✱ ✱✱✱ ATRA + GSK-J4 ns ✱✱✱ ns ✱✱✱EPZ ✱✱✱ ATRA EPZ + GSK-J4 ✱✱✱ ✱✱✱ ✱✱✱ 4✱✱✱ ATRA ✱✱✱✱✱✱ GMP DMSO ControlATRA✱✱✱ 200 ✱✱✱ ✱✱✱ ✱✱✱ ✱✱✱3 ✱✱✱ DMSO Control ✱✱✱ ns ATRA GSK-J4 ATRA + EPZ ✱✱✱ ✱✱✱ ATRA✱✱✱ + GSK-J4 ATRA + GSK-J4ATRA + GSK-J4 ✱✱✱4 ✱✱✱ 4 ✱✱✱✱✱✱ ✱✱✱ 4 ATRA✱✱✱ +GSK-J4 EPZ 3 ✱✱✱ ✱✱✱✱✱ ns ATRA GSK-J4 ATRA + EPZ ✱✱✱3 ✱✱✱ ns✱✱✱✱✱✱ ✱✱✱ ✱✱✱✱✱✱✱✱✱ns ATRA ✱✱✱ GSK-J4EPZ MEP ✱✱✱ 3 ATRA + EPZ ATRA + EPZ 4 ✱✱✱ ✱✱✱ ✱✱✱ 3 ns ns ✱✱ns✱✱✱ ✱✱✱EPZ ✱✱✱ ns ✱✱✱ GSK-J4EPZ✱✱ 3 ns 4 ✱✱✱✱✱ ✱✱✱ ns✱✱✱✱✱ATRA +GSK-J4 EPZ ✱✱✱ ✱✱✱ EPZ ATRA + GSK-J4 ✱✱✱ ✱✱✱ ✱✱✱ ✱✱✱ ✱✱✱ns✱✱✱ ✱✱✱ Monocyte EPZ ✱✱ ✱✱✱✱✱✱ ✱✱✱ATRA + GSK-J4 ✱✱✱ ✱✱✱✱✱✱ ATRA + GSK-J4 100 ✱✱✱ ✱✱✱ns ✱✱✱ ✱✱✱ 3✱✱✱ EPZ ns ✱✱✱ ATRA +✱✱✱ ATRAGSK-J4 + EPZ ✱✱✱ ✱✱✱ ✱✱✱✱✱✱✱✱✱ ✱✱✱ ✱✱✱ Erythroid ATRA +✱✱✱ GSK-J4 3 ✱✱✱ns ATRA + EPZ ✱✱✱3✱✱ ATRA + EPZ ns ATRA + EPZ ✱✱✱ ✱✱✱ 3 ATRAns + GSK-J4 ✱✱✱ ✱✱ H3K4em3 tag density tag H3K4em3 ✱✱ ✱✱✱2 ✱✱✱ ✱✱✱ 3✱✱ ns ATRA + EPZ 2 ✱✱✱ 2 ATRA + EPZ ✱✱✱ 3 ns ✱✱✱ ✱✱✱ ✱✱✱ ✱✱ Normalized H3K4me3 tags H3K4me3 Normalized ✱✱ ✱✱✱ 2 ✱✱✱ 0 2 ✱✱✱ ✱✱✱ ✱✱✱ 2 ✱✱✱ 2 2 ✱✱✱ 2 B GMP vs Erythroid GMP vs MEP 2 GMP vs MEP MEP vs Monocyte 1 1 2 CMP GMP MEP CMP2 GMP MEP CMP GMP MEP CMP GMP MEP GMP up-regulated GMP up-regulated MEP up-regulated MEP up-regulated MonocyteErythroid MonocyteErythroid 1 MonocyteErythroid MonocyteErythroid ✱✱✱ 1 ✱✱✱ DMSO Control DMSO Control 1 1 1 1 ✱✱✱ DMSO Control ✱✱✱ DMSO Control 0 ✱✱✱ 0 ✱✱✱✱✱✱✱✱✱ ✱✱✱✱✱✱ ATRADMSO Control 1 DMSO✱✱✱✱✱✱ ControlATRA DMSO ControlDMSO Control ✱✱✱✱✱✱ 1 4 3 days ATRA 6 days 4 9DMSO days✱✱✱ Control ✱✱✱ DMSO Control 1 3 days 6 days 9 days✱✱✱ DMSO ✱✱✱Control ✱✱✱ ATRAGSK-J4 0.25 CMP ✱✱✱ ATRAGSK-J4 ✱✱✱✱✱✱ ATRA 4 ✱✱✱ ✱✱✱ GSK-J4 4 ✱✱✱ ✱✱✱ ✱✱✱ DMSO Control ✱✱✱ 4 ✱✱✱✱✱✱ ATRA✱✱✱✱✱✱ 0 ✱✱✱✱✱✱ns ✱✱✱ 4 ATRA EPZ GSK-J4✱✱✱ 40 ✱✱✱ ✱✱✱ns ATRA EPZ GSK-J4 ✱✱✱✱✱✱✱✱✱✱✱✱ GMP ATRA GSK-J4 ATRA 4 ns ✱✱✱✱✱✱ 0 EPZ 0 ✱✱✱✱✱✱ 3 days 6 days 0 9 days✱✱✱ ✱✱✱ ATRA ✱✱✱ GSK-J4✱✱✱ ns ✱✱✱✱✱✱ ATRAEPZ + GSK-J4 4 4 ✱✱✱✱✱✱ns3 days ✱✱✱6 days✱✱✱4 9 days ATRAEPZ + GSK-J4✱✱✱40 ✱✱✱ns3 days ✱✱✱6 days 9 days EPZ 1.00 ✱✱✱ ✱✱✱✱✱✱ ✱✱✱ ✱✱✱✱✱✱ ATRA + GSK-J4 ✱✱✱3 ✱✱✱days ✱✱✱GSK-J4 6 days 9 days4✱✱✱ GSK-J4✱✱✱ ✱✱✱ ✱✱✱MEP ✱✱✱ GSK-J4 GSK-J4 GSK-J4 ✱✱✱ns 0 EPZ 03 ATRA✱✱✱ + EPZ 3 days 6 ATRAdays + + EPZ GSK-J4 9 days ✱✱✱ 3✱✱✱✱✱✱ ✱✱✱✱✱✱ns ✱✱✱ ✱✱✱ATRAns− + GSK-J4 ✱✱✱ ✱✱✱✱✱✱ ✱✱✱ATRA + GSK-J4 3 days✱✱✱ 6ATRA days + EPZ 9 days✱✱✱✱✱ 0✱✱✱✱✱ns ✱✱✱ ✱✱✱ EPZ 03 ✱✱✱ns ✱✱✱ ns ATRA + GSK-J4✱✱✱ 3ns 3 days ns ✱✱✱ 6 daysEPZ ATRA +9 EPZ days✱✱✱Monocyte✱✱✱EPZ
Recommended publications
  • Human and Mouse CD Marker Handbook Human and Mouse CD Marker Key Markers - Human Key Markers - Mouse
    Welcome to More Choice CD Marker Handbook For more information, please visit: Human bdbiosciences.com/eu/go/humancdmarkers Mouse bdbiosciences.com/eu/go/mousecdmarkers Human and Mouse CD Marker Handbook Human and Mouse CD Marker Key Markers - Human Key Markers - Mouse CD3 CD3 CD (cluster of differentiation) molecules are cell surface markers T Cell CD4 CD4 useful for the identification and characterization of leukocytes. The CD CD8 CD8 nomenclature was developed and is maintained through the HLDA (Human Leukocyte Differentiation Antigens) workshop started in 1982. CD45R/B220 CD19 CD19 The goal is to provide standardization of monoclonal antibodies to B Cell CD20 CD22 (B cell activation marker) human antigens across laboratories. To characterize or “workshop” the antibodies, multiple laboratories carry out blind analyses of antibodies. These results independently validate antibody specificity. CD11c CD11c Dendritic Cell CD123 CD123 While the CD nomenclature has been developed for use with human antigens, it is applied to corresponding mouse antigens as well as antigens from other species. However, the mouse and other species NK Cell CD56 CD335 (NKp46) antibodies are not tested by HLDA. Human CD markers were reviewed by the HLDA. New CD markers Stem Cell/ CD34 CD34 were established at the HLDA9 meeting held in Barcelona in 2010. For Precursor hematopoetic stem cell only hematopoetic stem cell only additional information and CD markers please visit www.hcdm.org. Macrophage/ CD14 CD11b/ Mac-1 Monocyte CD33 Ly-71 (F4/80) CD66b Granulocyte CD66b Gr-1/Ly6G Ly6C CD41 CD41 CD61 (Integrin b3) CD61 Platelet CD9 CD62 CD62P (activated platelets) CD235a CD235a Erythrocyte Ter-119 CD146 MECA-32 CD106 CD146 Endothelial Cell CD31 CD62E (activated endothelial cells) Epithelial Cell CD236 CD326 (EPCAM1) For Research Use Only.
    [Show full text]
  • Single-Cell RNA Sequencing Demonstrates the Molecular and Cellular Reprogramming of Metastatic Lung Adenocarcinoma
    ARTICLE https://doi.org/10.1038/s41467-020-16164-1 OPEN Single-cell RNA sequencing demonstrates the molecular and cellular reprogramming of metastatic lung adenocarcinoma Nayoung Kim 1,2,3,13, Hong Kwan Kim4,13, Kyungjong Lee 5,13, Yourae Hong 1,6, Jong Ho Cho4, Jung Won Choi7, Jung-Il Lee7, Yeon-Lim Suh8,BoMiKu9, Hye Hyeon Eum 1,2,3, Soyean Choi 1, Yoon-La Choi6,10,11, Je-Gun Joung1, Woong-Yang Park 1,2,6, Hyun Ae Jung12, Jong-Mu Sun12, Se-Hoon Lee12, ✉ ✉ Jin Seok Ahn12, Keunchil Park12, Myung-Ju Ahn 12 & Hae-Ock Lee 1,2,3,6 1234567890():,; Advanced metastatic cancer poses utmost clinical challenges and may present molecular and cellular features distinct from an early-stage cancer. Herein, we present single-cell tran- scriptome profiling of metastatic lung adenocarcinoma, the most prevalent histological lung cancer type diagnosed at stage IV in over 40% of all cases. From 208,506 cells populating the normal tissues or early to metastatic stage cancer in 44 patients, we identify a cancer cell subtype deviating from the normal differentiation trajectory and dominating the metastatic stage. In all stages, the stromal and immune cell dynamics reveal ontological and functional changes that create a pro-tumoral and immunosuppressive microenvironment. Normal resident myeloid cell populations are gradually replaced with monocyte-derived macrophages and dendritic cells, along with T-cell exhaustion. This extensive single-cell analysis enhances our understanding of molecular and cellular dynamics in metastatic lung cancer and reveals potential diagnostic and therapeutic targets in cancer-microenvironment interactions. 1 Samsung Genome Institute, Samsung Medical Center, Seoul 06351, Korea.
    [Show full text]
  • CD45) 6 7 8 9 10 11 12 13 Melissa L
    bioRxiv preprint doi: https://doi.org/10.1101/2020.09.29.318709; this version posted September 29, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. 1 2 3 4 5 The roseoloviruses downregulate the protein tyrosine phosphatase PTPRC (CD45) 6 7 8 9 10 11 12 13 Melissa L. Whyte1, Kelsey Smith1, Amanda Buchberger2,4, Linda Berg Luecke 4, Lidya 14 Handayani Tjan3, Yasuko Mori3, Rebekah L Gundry2,4, and Amy W. Hudson1# 15 16 17 18 19 20 21 22 23 24 25 26 27 1: Department of Microbiology and Immunology, Medical College of Wisconsin, Milwaukee, WI 28 2. Department of Biochemistry, Medical College of Wisconsin, Milwaukee, WI 29 3. Division of Clinical Virology, Kobe University Graduate School of Medicine, Kobe, Japan 30 4: Current address: CardiOmics Program, Center for Heart and Vascular Research; Division of 31 Cardiovascular Medicine; and Department of Cellular and Integrative Physiology, University of 32 Nebraska Medical Center, Omaha, NE 33 34 35 36 #To whom correspondence should be addressed: [email protected] 37 38 39 40 Runnning title: Roseolovirus downregulation of CD45 41 42 43 44 45 46 1 bioRxiv preprint doi: https://doi.org/10.1101/2020.09.29.318709; this version posted September 29, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. 47 Abstract 48 Like all herpesviruses, the roseoloviruses (HHV6A, -6B, and -7) establish lifelong 49 infection within their host, requiring these viruses to evade host anti-viral responses.
    [Show full text]
  • Protein Tyrosine Phosphatase Receptor Type C (PTPRC Or CD45)
    Molecules in pathogenesis Protein tyrosine phosphatase receptor type C (PTPRC J Clin Pathol: first published as 10.1136/jclinpath-2020-206927 on 26 May 2021. Downloaded from or CD45) Maryam Ahmed Al Barashdi ,1 Ahlam Ali,1 Mary Frances McMullin ,2 Ken Mills1 1Patrick G Johnston Centre for ABSTRACT The extracellular portion of the CD45 consists of Cancer Research (PGJCCR), The leucocyte common antigen, protein tyrosine five regions (figure 1). The extended N-terminal Queen’s University Belfast, region has alternatively spliced exons, with several Belfast, UK phosphatase receptor type C (PTPRC), also known as 2Haematology, Belfast City CD45, is a transmembrane glycoprotein, expressed regions for O- linked glycosylation and thus form Hospital, Belfast, UK on almost all haematopoietic cells except for mature the protein variable area. All species have a similar erythrocytes, and is an essential regulator of T and B structure of the CD45 extracellular domain, the Correspondence to cell antigen receptor-mediated activation. Disruption three membrane- proximal portion and the type III Maryam Ahmed Al Barashdi, of the equilibrium between protein tyrosine kinase and fibronectin (FnIII) domain. In mammals, between Medicine, Queen’s University the O- glycan tract and FnIII domains, a globular Belfast, Belfast BT7 1NN, UK; phosphatase activity (from CD45 and others) can result malbarashdi01@ qub. ac. uk in immunodeficiency, autoimmunity, or malignancy. domain exists with five conserved cysteine- rich CD45 is normally present on the cell surface, therefore domains (figure 1).4 Received 3 August 2020 it works upstream of a large signalling network which The CD45 gene, protein tyrosine phosphatase Accepted 16 February 2021 differs between cell types, and thus the effects of CD45 receptor type C (PTPRC), consists of 35 exons, four on these cells are also different.
    [Show full text]
  • Single-Cell Transcriptome Profiling of the Kidney Glomerulus Identifies Key Cell Types and Reactions to Injury
    BASIC RESEARCH www.jasn.org Single-Cell Transcriptome Profiling of the Kidney Glomerulus Identifies Key Cell Types and Reactions to Injury Jun-Jae Chung ,1 Leonard Goldstein ,2 Ying-Jiun J. Chen,2 Jiyeon Lee ,1 Joshua D. Webster,3 Merone Roose-Girma,2 Sharad C. Paudyal,4 Zora Modrusan,2 Anwesha Dey,5 and Andrey S. Shaw1 Due to the number of contributing authors, the affiliations are listed at the end of this article. ABSTRACT Background The glomerulus is a specialized capillary bed that is involved in urine production and BP control. Glomerular injury is a major cause of CKD, which is epidemic and without therapeutic options. Single-cell transcriptomics has radically improved our ability to characterize complex organs, such as the kidney. Cells of the glomerulus, however, have been largely underrepresented in previous single-cell kidney studies due to their paucity and intractability. Methods Single-cell RNA sequencing comprehensively characterized the types of cells in the glomerulus from healthy mice and from four different disease models (nephrotoxic serum nephritis, diabetes, doxo- rubicin toxicity, and CD2AP deficiency). Results Allcelltypesintheglomeruluswereidentified using unsupervised clustering analysis. Novel marker genes and gene signatures of mesangial cells, vascular smooth muscle cells of the afferent and efferent arteri- oles, parietal epithelial cells, and three types of endothelial cells were identified. Analysis of the disease models revealed cell type–specific and injury type–specific responses in the glomerulus, including acute activation of the Hippo pathway in podocytes after nephrotoxic immune injury. Conditional deletion of YAP or TAZ resulted in more severe and prolonged proteinuria in response to injury, as well as worse glomerulosclerosis.
    [Show full text]
  • Recent Discoveries of Macromolecule- and Cell-Based Biomarkers and Therapeutic Implications in Breast Cancer
    International Journal of Molecular Sciences Review Recent Discoveries of Macromolecule- and Cell-Based Biomarkers and Therapeutic Implications in Breast Cancer Hsing-Ju Wu 1,2,3 and Pei-Yi Chu 4,5,6,7,* 1 Department of Biology, National Changhua University of Education, Changhua 500, Taiwan; [email protected] 2 Research Assistant Center, Show Chwan Memorial Hospital, Changhua 500, Taiwan 3 Department of Medical Research, Chang Bing Show Chwan Memorial Hospital, Lukang Town, Changhua County 505, Taiwan 4 School of Medicine, College of Medicine, Fu Jen Catholic University, New Taipei City 231, Taiwan 5 Department of Pathology, Show Chwan Memorial Hospital, No. 542, Sec. 1 Chung-Shan Rd., Changhua 500, Taiwan 6 Department of Health Food, Chung Chou University of Science and Technology, Changhua 510, Taiwan 7 National Institute of Cancer Research, National Health Research Institutes, Tainan 704, Taiwan * Correspondence: [email protected]; Tel.: +886-975-611-855; Fax: +886-4-7227-116 Abstract: Breast cancer is the most commonly diagnosed cancer type and the leading cause of cancer-related mortality in women worldwide. Breast cancer is fairly heterogeneous and reveals six molecular subtypes: luminal A, luminal B, HER2+, basal-like subtype (ER−, PR−, and HER2−), normal breast-like, and claudin-low. Breast cancer screening and early diagnosis play critical roles in improving therapeutic outcomes and prognosis. Mammography is currently the main commercially available detection method for breast cancer; however, it has numerous limitations. Therefore, reliable noninvasive diagnostic and prognostic biomarkers are required. Biomarkers used in cancer range from macromolecules, such as DNA, RNA, and proteins, to whole cells.
    [Show full text]
  • Theranostics Aberrant Activation of the CD45-Wnt Signaling Axis Promotes Stemness and Therapy Resistance in Colorectal Cancer Ce
    Theranostics 2021, Vol. 11, Issue 18 8755 Ivyspring International Publisher Theranostics 2021; 11(18): 8755-8770. doi: 10.7150/thno.63446 Research Paper Aberrant activation of the CD45-Wnt signaling axis promotes stemness and therapy resistance in colorectal cancer cells So-Yeon Park1,2, Ji-Young Kim1, Gyu-Beom Jang1, Jang-Hyun Choi1, Jee-Heun Kim1, Choong-Jae Lee1, Sunjae Lee1, Jeong-Heum Baek3, Kwan-Kyu Park4, Jin-Man Kim5, Hee Jin Chang6, Nam-Chul Cho7, and Jeong-Seok Nam1,2 1. School of Life Sciences, Gwangju Institute of Science and Technology, Gwangju 61005, Republic of Korea. 2. Cell Logistics Research Center, Gwangju Institute of Science and Technology, Gwangju 61005, Republic of Korea. 3. Division of Colon and Rectal Surgery, Department of Surgery, Gil Medical Center, Gachon University College of Medicine, Incheon 21999, Republic of Korea. 4. Department of Pathology, College of Medicine, Catholic University of Daegu, College of Medicine, Daegu 38430, Republic of Korea. 5. Department of Pathology, College of Medicine, Chungnam National University, Daejeon 34134, Republic of Korea. 6. Research Institute and Hospital, National Cancer Center, Goyang 10408, Republic of Korea. 7. Drug Information Platform Center, Korea Research Institute of Chemical Technology, Daejeon 34114, Republic of Korea. Corresponding author: Jeong-Seok Nam, School of Life Sciences, Gwangju Institute of Science and Technology, Gwangju 61005, Republic of Korea. E-mail: [email protected]; Phone: +82-62-715-2893; Fax: +82-62-715-2484. © The author(s). This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/).
    [Show full text]
  • Human CD Marker Chart Reviewed by HLDA1 Bdbiosciences.Com/Cdmarkers
    BD Biosciences Human CD Marker Chart Reviewed by HLDA1 bdbiosciences.com/cdmarkers 23-12399-01 CD Alternative Name Ligands & Associated Molecules T Cell B Cell Dendritic Cell NK Cell Stem Cell/Precursor Macrophage/Monocyte Granulocyte Platelet Erythrocyte Endothelial Cell Epithelial Cell CD Alternative Name Ligands & Associated Molecules T Cell B Cell Dendritic Cell NK Cell Stem Cell/Precursor Macrophage/Monocyte Granulocyte Platelet Erythrocyte Endothelial Cell Epithelial Cell CD Alternative Name Ligands & Associated Molecules T Cell B Cell Dendritic Cell NK Cell Stem Cell/Precursor Macrophage/Monocyte Granulocyte Platelet Erythrocyte Endothelial Cell Epithelial Cell CD1a R4, T6, Leu6, HTA1 b-2-Microglobulin, CD74 + + + – + – – – CD93 C1QR1,C1qRP, MXRA4, C1qR(P), Dj737e23.1, GR11 – – – – – + + – – + – CD220 Insulin receptor (INSR), IR Insulin, IGF-2 + + + + + + + + + Insulin-like growth factor 1 receptor (IGF1R), IGF-1R, type I IGF receptor (IGF-IR), CD1b R1, T6m Leu6 b-2-Microglobulin + + + – + – – – CD94 KLRD1, Kp43 HLA class I, NKG2-A, p39 + – + – – – – – – CD221 Insulin-like growth factor 1 (IGF-I), IGF-II, Insulin JTK13 + + + + + + + + + CD1c M241, R7, T6, Leu6, BDCA1 b-2-Microglobulin + + + – + – – – CD178, FASLG, APO-1, FAS, TNFRSF6, CD95L, APT1LG1, APT1, FAS1, FASTM, CD95 CD178 (Fas ligand) + + + + + – – IGF-II, TGF-b latency-associated peptide (LAP), Proliferin, Prorenin, Plasminogen, ALPS1A, TNFSF6, FASL Cation-independent mannose-6-phosphate receptor (M6P-R, CIM6PR, CIMPR, CI- CD1d R3G1, R3 b-2-Microglobulin, MHC II CD222 Leukemia
    [Show full text]
  • Genetic Variation Contributes to Gene Expression Response in Ischemic Stroke: an Eqtl Study
    UC Davis UC Davis Previously Published Works Title Genetic variation contributes to gene expression response in ischemic stroke: an eQTL study. Permalink https://escholarship.org/uc/item/3v01424z Journal Annals of clinical and translational neurology, 7(9) ISSN 2328-9503 Authors Amini, Hajar Shroff, Natasha Stamova, Boryana et al. Publication Date 2020-09-01 DOI 10.1002/acn3.51154 Peer reviewed eScholarship.org Powered by the California Digital Library University of California RESEARCH ARTICLE Genetic variation contributes to gene expression response in ischemic stroke: an eQTL study Hajar Amini , Natasha Shroff, Boryana Stamova, Eva Ferino, Paulina Carmona-Mora, Xinhua Zhan, Preston P. Sitorus, Heather Hull, Glen C. Jickling, Frank R. Sharp & Bradley P. Ander Department of Neurology, University of California at Davis, Sacramento, California, 95817 Correspondence Abstract Hajar Amini and Bradley P. Ander, Objective Department of Neurology, University of : Single nucleotide polymorphisms (SNPs) contribute to complex dis- California at Davis, MIND Institute orders such as ischemic stroke (IS). Since SNPs could affect IS by altering gene Biosciences Building, 2805 50th Street, Room expression, we studied the association of common SNPs with changes in mRNA 2434, Sacramento, CA 95817. Phone: 916- expression (i.e. expression quantitative trait loci; eQTL) in blood after IS. 703-0384; Fax: 916-703-0369; E-mail: Methods: RNA and DNA were isolated from 137 patients with acute IS and [email protected], [email protected] 138 vascular risk factor controls (VRFC). Gene expression was measured using Affymetrix HTA 2.0 microarrays and SNP variants were assessed with Axiom Funding Information Biobank Genotyping microarrays. A linear model with a genotype (SNP) 9 These studies were supported by grants from diagnosis (IS and VRFC) interaction term was fit for each SNP-gene pair.
    [Show full text]
  • A Graph-Theoretic Approach to Model Genomic Data and Identify Biological Modules Asscociated with Cancer Outcomes
    A Graph-Theoretic Approach to Model Genomic Data and Identify Biological Modules Asscociated with Cancer Outcomes Deanna Petrochilos A dissertation presented in partial fulfillment of the requirements for the degree of Doctor of Philosophy University of Washington 2013 Reading Committee: Neil Abernethy, Chair John Gennari, Ali Shojaie Program Authorized to Offer Degree: Biomedical Informatics and Health Education UMI Number: 3588836 All rights reserved INFORMATION TO ALL USERS The quality of this reproduction is dependent upon the quality of the copy submitted. In the unlikely event that the author did not send a complete manuscript and there are missing pages, these will be noted. Also, if material had to be removed, a note will indicate the deletion. UMI 3588836 Published by ProQuest LLC (2013). Copyright in the Dissertation held by the Author. Microform Edition © ProQuest LLC. All rights reserved. This work is protected against unauthorized copying under Title 17, United States Code ProQuest LLC. 789 East Eisenhower Parkway P.O. Box 1346 Ann Arbor, MI 48106 - 1346 ©Copyright 2013 Deanna Petrochilos University of Washington Abstract Using Graph-Based Methods to Integrate and Analyze Cancer Genomic Data Deanna Petrochilos Chair of the Supervisory Committee: Assistant Professor Neil Abernethy Biomedical Informatics and Health Education Studies of the genetic basis of complex disease present statistical and methodological challenges in the discovery of reliable and high-confidence genes that reveal biological phenomena underlying the etiology of disease or gene signatures prognostic of disease outcomes. This dissertation examines the capacity of graph-theoretical methods to model and analyze genomic information and thus facilitate using prior knowledge to create a more discrete and functionally relevant feature space.
    [Show full text]
  • Receptor Protein-Tyrosine Phosphatases Controlling Activity of the Oncoprotein
    Receptor protein-tyrosine phosphatases controlling activity of the oncoprotein FLT3 ITD Dissertation zur Erlangung des akademischen Grades Doctor rerum naturalium (Dr. rer. nat.) vorgelegt dem Rat der Medizinischen Fakultät der Friedrich-Schiller-Universität Jena vorgelegt von M. Sc. Anne Kresinsky geboren am 13.05.1990 in Elsterwerda Gutachter: 1. PD Dr. rer. nat. habil. Jörg Paul Müller, Universitätsklinikum Jena 2. Apl. Prof. Dr. rer. nat. habil. Frank-Dietmar Böhmer, Universitätsklinikum Jena 3. Prof. Dr. med. habil. Carsten Müller-Tidow, Universitätsklinikum Heidelberg Tag der öffentlichen Verteidigung: 15.01.2019 Table of Contents Table of Contents TABLE OF CONTENTS .................................................................................................. I ABBREVIATIONS .......................................................................................................... V ZUSAMMENFASSUNG ............................................................................................... VII SUMMARY .................................................................................................................... IX 1. INTRODUCTION ........................................................................................................ 1 1.1 Hematopoietic system ............................................................................................ 1 1.2 Acute myeloid leukemia (AML) .............................................................................. 2 1.2.1 General aspects of AML ....................................................................................
    [Show full text]
  • Mouse CD Marker Chart Bdbiosciences.Com/Cdmarkers
    BD Mouse CD Marker Chart bdbiosciences.com/cdmarkers 23-12400-01 CD Alternative Name Ligands & Associated Molecules T Cell B Cell Dendritic Cell NK Cell Stem Cell/Precursor Macrophage/Monocyte Granulocyte Platelet Erythrocyte Endothelial Cell Epithelial Cell CD Alternative Name Ligands & Associated Molecules T Cell B Cell Dendritic Cell NK Cell Stem Cell/Precursor Macrophage/Monocyte Granulocyte Platelet Erythrocyte Endothelial Cell Epithelial Cell CD Alternative Name Ligands & Associated Molecules T Cell B Cell Dendritic Cell NK Cell Stem Cell/Precursor Macrophage/Monocyte Granulocyte Platelet Erythrocyte Endothelial Cell Epithelial Cell CD1d CD1.1, CD1.2, Ly-38 Lipid, Glycolipid Ag + + + + + + + + CD104 Integrin b4 Laminin, Plectin + DNAX accessory molecule 1 (DNAM-1), Platelet and T cell CD226 activation antigen 1 (PTA-1), T lineage-specific activation antigen 1 CD112, CD155, LFA-1 + + + + + – + – – CD2 LFA-2, Ly-37, Ly37 CD48, CD58, CD59, CD15 + + + + + CD105 Endoglin TGF-b + + antigen (TLiSA1) Mucin 1 (MUC1, MUC-1), DF3 antigen, H23 antigen, PUM, PEM, CD227 CD54, CD169, Selectins; Grb2, β-Catenin, GSK-3β CD3g CD3g, CD3 g chain, T3g TCR complex + CD106 VCAM-1 VLA-4 + + EMA, Tumor-associated mucin, Episialin + + + + + + Melanotransferrin (MT, MTF1), p97 Melanoma antigen CD3d CD3d, CD3 d chain, T3d TCR complex + CD107a LAMP-1 Collagen, Laminin, Fibronectin + + + CD228 Iron, Plasminogen, pro-UPA (p97, MAP97), Mfi2, gp95 + + CD3e CD3e, CD3 e chain, CD3, T3e TCR complex + + CD107b LAMP-2, LGP-96, LAMP-B + + Lymphocyte antigen 9 (Ly9),
    [Show full text]